A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults
Trial details
- Registry ID
- NCT04668339
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy AdultsNCT04668339 | Arcturus Therapeutics, Inc. | Phase 2 | Terminated | 2022-03-01Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |